Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

- PMLiVE

Maastricht joins the Health Axis Europe

Will join Cambridge, Leuven and Heidelberg in the alliance

- PMLiVE

AZ appoints Pam Cheng as executive VP, operations and IT

She joins from MSD China where she was president

- PMLiVE

Why pharma needs to fall in love with creativity

As Cannes plays host to Lions Health, Shaheed Peera looks beyond default 'creative' settings

- PMLiVE

Former Opinion Matters founder launches new agency

Yolo Communications aims to build on social media strategies

- PMLiVE

GCI Health makes senior promotions

Builds upon recent appointments to the med comms agency

National Institute for Health and Care Excellence NICE logo

NICE opens consultation on Gilead’s leukaemia drug

Comes after the Institute rejects the treatment in new draft guidance

Biomarin

BioMarin drug boosts growth in children with dwarfism

Vosoritide showed results in 50% of trial participants

Allergan logo

Allergan inks $2.1bn deal to buy cosmetic drug firm Kythera

Company will add Kythera’s double chin therapy Kybella to its portfolio

- PMLiVE

RSA appoint Paul Cashman as partner for global clients

He joins from AbbVie where he held the same role

- PMLiVE

CROS NT names Mark Paul as senior VP of US operations

He joins from Veracity Logic

- PMLiVE

AZ and Inserm collaborate on diabetes and kidney disease

Three-year partnership will look at new therapeutic approaches

Allergan logo

More waiting for Allergan and Gedeon Richter’s antipsychotic

FDA announced it will take another three months to review cariprazine for schizophrenia

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links